Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
220
Trial Sponsor
Clinical Trial Start Date
November 25, 2020
0Primary Completion Date
July 18, 2021
0Study Completion Date
July 18, 2021
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Device0
Intervention Name
Facial skin treatment0
Interventional Trial Phase
Not Applicable0
Official Name
Prospective, Single-Center, Open-Label Study to Evaluate the Efficacy of the Alma Hybrid System for New Approach of Facial Skin Treatment With Minimal Downtime0
Last Updated
July 22, 2021
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
The study is aimed to evaluate the efficacy of the Alma Hybrid system for a new approach of facial skin treatment, using both ablative and non-ablative wavelengths. The study will include 20 subjects with mild-moderate photodamaged skin, that will undergo 2 facial skin treatments. Follow up visit to evaluate the efficacy of the treatments will take place 1 and 3 months after the last treatment.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
